| Sources | Names Used |
|---|---|
| GDSC1000 | KIN001-260 |
| PharmacoGx | KIN001-260 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LMO3 | GDSC1000 | pan-cancer | AAC | 0.057 | 0.08 |
| mRNA | CLNS1A | GDSC1000 | pan-cancer | AAC | 0.056 | 0.08 |
| mRNA | SYCE1L | GDSC1000 | pan-cancer | AAC | -0.056 | 0.08 |
| mRNA | OR4S1 | GDSC1000 | pan-cancer | AAC | 0.054 | 0.08 |
| mRNA | MBD5 | GDSC1000 | pan-cancer | AAC | 0.057 | 0.08 |
| mRNA | RNF217 | GDSC1000 | pan-cancer | AAC | 0.061 | 0.08 |
| mRNA | CMTM5 | GDSC1000 | pan-cancer | AAC | 0.055 | 0.08 |
| mRNA | ATG2B | GDSC1000 | pan-cancer | AAC | 0.056 | 0.08 |
| mRNA | CNTF | GDSC1000 | pan-cancer | AAC | -0.054 | 0.08 |
| mRNA | IKBKB | GDSC1000 | pan-cancer | AAC | 0.059 | 0.08 |
